Cristóbal, I.; Santos, A.; Rubio, J.; Caramés, C.; Zazo, S.; Sanz-Álvarez, M.; Luque, M.; Madoz-Gúrpide, J.; Rojo, F.; García-Foncillas, J.
Validation of microRNA-199b as A Promising Predictor of Outcome and Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer Patients. Cancers 2021, 13, 5003.
https://doi.org/10.3390/cancers13195003
AMA Style
Cristóbal I, Santos A, Rubio J, Caramés C, Zazo S, Sanz-Álvarez M, Luque M, Madoz-Gúrpide J, Rojo F, García-Foncillas J.
Validation of microRNA-199b as A Promising Predictor of Outcome and Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer Patients. Cancers. 2021; 13(19):5003.
https://doi.org/10.3390/cancers13195003
Chicago/Turabian Style
Cristóbal, Ion, Andrea Santos, Jaime Rubio, Cristina Caramés, Sandra Zazo, Marta Sanz-Álvarez, Melani Luque, Juan Madoz-Gúrpide, Federico Rojo, and Jesús García-Foncillas.
2021. "Validation of microRNA-199b as A Promising Predictor of Outcome and Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer Patients" Cancers 13, no. 19: 5003.
https://doi.org/10.3390/cancers13195003
APA Style
Cristóbal, I., Santos, A., Rubio, J., Caramés, C., Zazo, S., Sanz-Álvarez, M., Luque, M., Madoz-Gúrpide, J., Rojo, F., & García-Foncillas, J.
(2021). Validation of microRNA-199b as A Promising Predictor of Outcome and Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer Patients. Cancers, 13(19), 5003.
https://doi.org/10.3390/cancers13195003